Telix's Illuccix PSMA─PET imaging agent approved in Portugal
Telix, a commercial-stage biopharmaceutical company, announces that its prostate cancer PET imaging agent, Illuccix (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing authorization in Portugal by INFARMED for the …